Status:

COMPLETED

Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia

Lead Sponsor:

Yale University

Conditions:

Opiate Dependence

Stimulant Dependence

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

To evaluate the tolerability, acceptability and potential effect size of the efficacy of 4 months of atomoxetine treatment for patients with co-occurring ATS and heroin dependence (COATS) receiving bu...

Detailed Description

The Specific Aims of the proposed study are: 1. To evaluate the tolerability, acceptability and potential effect size of the efficacy of 4 months of atomoxetine treatment for patients with co-occurri...

Eligibility Criteria

Inclusion

  • Meet Opioid and Amphetamine-type stimulant (ATS)dependence, as assessed by the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM-IV) (SCID) and documented by opioid-positive and ATS positive urine tests.
  • Report at least 2 or more days per week of ATS use over the past month.

Exclusion

  • Hypersensitivity to atomoxetine;
  • Current use of a monoamine oxidase inhibitor (MAOI) or use within the preceding 2 weeks;
  • Suffer from narrow angle glaucoma; pheochromocytoma; severe cardiovascular disorder; liver enzymes greater than 3 times the upper limit of normal; liver failure or acute hepatitis;
  • Pregnancy or breast feeding;
  • Current suicide or homicide risk;
  • Current psychotic disorder or major depression;
  • Inability to understand the protocol or assessment questions.
  • A physician reviews the results of all baseline assessments and laboratory and other medical tests (CBC, chemistries, liver enzymes, HIV and Hepatitis B and C, EKG, chest x-ray), takes a medical history, and performs a physical examination in order to confirm the patient's eligibility for the study.

Key Trial Info

Start Date :

May 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT01863251

Start Date

May 1 2013

End Date

September 1 2014

Last Update

April 27 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universiti Sains Malaysia

Kota Bharu, Malaysia